Developer of a non-toxic drug to fight excess weight and obesity.
Employees: 7
Main Markets:
Pharmaceuticals companies, People that suffer from overweight.
Overview
LEAN-EX is developer of a series of drugs named SlimAx , which
Click here to request more information, about this company (FOR COLLABORATION IN R&D. ONLY!)
Note - you have to be registered in this server to
request information. If you haven't done so
yet, please register in this server
Your requests will be forwarded to the developer, who
will contact you directly
You can also see the list of
documents you already requested more information about
are derivatives of natural amino acids conceived to counteract
fat deposition.
LEAN-EX LTD. develops and designs novel and patented drugs for
fighting obesity and other conditions relating to it. The Company
has created a new paradigm by which the body is empowered to
metabolise fat rather than carbohydrates and effectively change
its metabolic pathway. The metabolic change leads to the
elimination of new fat storage in the adipose tissue and creates
an accelerated fat depletion rate.
The Company's R&D objectives include the following:
* Commence Phase I and II human clinical trials of SBS
respectively
* Secure a large development partner to accelerate R&D activities
during Phase II and III clinical trials
* Attempt to locate, prove and patent other indications based on
its patented compounds
* Commercialize SBS' veterinary indications.
